6 patents
Utility
Oxygen Linked Pyrimidine Derivatives
4 Aug 22
The present invention relates to pyrimidine compounds that are useful as anti-proliferative agents.
Stephanie Blanchard, Cheng Hsia Angeline Lee, Harish Kumar Mysore Nagaraj, Anders Poulsen, Eric T. Sun, Yee Ling Evelyn Tan, Anthony Deodaunia William
Filed: 2 Sep 21
Utility
Methods of Treating FLT3-MUTATED Hematologic Cancers
13 Jan 22
Methods to inhibit FLT3 activity in a subject or a cell with an FLT3 mutation are provided.
Bhavana BHATNAGAR, Sharyn D. BAKER
Filed: 1 Oct 19
Utility
Oxygen linked pyrimidine derivatives
5 Oct 21
The present invention relates to pyrimidine compounds that are useful as anti-proliferative agents.
Stephanie Blanchard, Cheng Hsia Angelina Lee, Harish Kumar Mysore Nagaraj, Anders Poulsen, Eric T. Sun, Yee Ling Evelyn Tan, Anthony Deodaunia William
Filed: 7 Nov 19
Utility
Methods of Treating Transplant Rejection
11 Mar 21
The present invention provides the use of protein kinase inhibitors, in particular JAK2 inhibitors of formula (I), as set forth in the specification, in the treatment of solid organ transplant rejection and graft versus host disease (GvHD).
Brian C. Betts, Xuezhong Yu, Claudio Anasetti
Filed: 16 Nov 20
Utility
Oxygen Linked Pyrimidine Derivatives
4 Mar 20
The present invention relates to pyrimidine compounds that are useful as anti-proliferative agents.
Stephanie Blanchard, Cheng Hsia Angelina Lee, Harish Kumar Mysore Nagaraj, Anders Poulsen, Eric T. Sun, Yee Ling Evelyn Tan, Anthony Deodaunia William
Filed: 6 Nov 19
Utility
Oxygen linked pyrimidine derivatives
30 Dec 19
The present invention relates to pyrimidine compounds that are useful as anti-proliferative agents.
Stephanie Blanchard, Cheng Hsia Angeline Lee, Harish Kumar Mysore Nagaraj, Anders Poulsen, Eric T. Sun, Yee Ling Evelyn Tan, Anthony Deodaunia William
Filed: 4 Jan 17
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first